Takeda Secures FDA & Japan Approvals, Boosting Rare‑Disease Pipeline
Takeda’s FDA approval of Mimrylo and Japan’s acceptance of ORZEYFUL boost rare‑disease options for polycythemia vera and narcolepsy, expanding global reach and portfolio depth.
3 minutes to read